Ocular Therapeutix Inc (OCUL)
4.20
-0.44
(-9.58%)
USD |
NASDAQ |
Apr 25, 16:00
4.20
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Cash and Short Term Investments (Quarterly): 195.81M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 195.81M |
| September 30, 2023 | 110.55M |
| June 30, 2023 | 66.61M |
| March 31, 2023 | 79.03M |
| December 31, 2022 | 102.30M |
| September 30, 2022 | 120.95M |
| June 30, 2022 | 134.54M |
| March 31, 2022 | 145.42M |
| December 31, 2021 | 164.16M |
| September 30, 2021 | 179.28M |
| June 30, 2021 | 191.86M |
| March 31, 2021 | 209.38M |
| December 31, 2020 | 228.06M |
| September 30, 2020 | 70.64M |
| June 30, 2020 | 84.29M |
| March 31, 2020 | 48.15M |
| December 31, 2019 | 54.44M |
| September 30, 2019 | 65.41M |
| June 30, 2019 | 61.76M |
| March 31, 2019 | 76.25M |
| December 31, 2018 | 54.06M |
| Date | Value |
|---|---|
| September 30, 2018 | 56.86M |
| June 30, 2018 | 56.83M |
| March 31, 2018 | 62.91M |
| December 31, 2017 | 41.54M |
| September 30, 2017 | 51.16M |
| June 30, 2017 | 66.05M |
| March 31, 2017 | 80.38M |
| December 31, 2016 | 68.14M |
| September 30, 2016 | 75.75M |
| June 30, 2016 | 83.89M |
| March 31, 2016 | 95.46M |
| December 31, 2015 | 105.06M |
| September 30, 2015 | 113.64M |
| June 30, 2015 | 123.72M |
| March 31, 2015 | 67.42M |
| December 31, 2014 | 74.83M |
| September 30, 2014 | 80.89M |
| June 30, 2014 | 19.94M |
| March 31, 2014 | 12.75M |
| December 31, 2013 | 17.50M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
48.15M
Minimum
Mar 2020
228.06M
Maximum
Dec 2020
121.72M
Average
110.55M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Assertio Holdings Inc | 73.44M |
| CytomX Therapeutics Inc | 174.51M |
| EyePoint Pharmaceuticals Inc | 331.05M |
| Regeneron Pharmaceuticals Inc | 10.84B |
| Cormedix Inc | 76.03M |